semaglutide oral dose for weight loss side effects - Uses | Limitations Effects of oral semaglutide on

In rodents, increased intestinal gluconeogenesis results in a reduction in hepatic gluconeogenesis, appetite and weight, leading to improved glucose homeostasis

Brand Options and FDA Approval: Wegovy is FDA-approved for chronic weight management

A.SenieR

When to Contact Your Doctor About Dizziness During GLP-1 Therapy Mild dizziness that improves within a few days of starting or increasing your dose may reflect normal adjustment and often resolves with adequate hydration and slower dose escalation

The most common side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and mild injection-site reactions such as redness or swelling